FSCVX
Price
$26.75
Change
-$0.10 (-0.37%)
Updated
Dec 2 closing price
Net Assets
270.61M
VSIIX
Price
$50.98
Change
+$0.54 (+1.07%)
Updated
Dec 3 closing price
Net Assets
58.35B
Interact to see
Advertisement

FSCVX vs VSIIX

Header iconFSCVX vs VSIIX Comparison
Open Charts FSCVX vs VSIIXBanner chart's image
Nuveen Small Cap Value C
Price$26.75
Change-$0.10 (-0.37%)
VolumeN/A
Net Assets270.61M
Vanguard Small Cap Value Index I
Price$50.98
Change+$0.54 (+1.07%)
VolumeN/A
Net Assets58.35B
FSCVX vs VSIIX Comparison Chart in %
View a ticker or compare two or three
VS
FSCVX vs. VSIIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSCVX is a Hold and VSIIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIIX has more cash in the bank: 58.3B vs. FSCVX (271M). VSIIX pays higher dividends than FSCVX: VSIIX (1.98) vs FSCVX (0.56). FSCVX was incepted earlier than VSIIX: FSCVX (27 years) vs VSIIX (26 years). FSCVX (2.06) is less costly to investors than VSIIX (0.06). FSCVX is a more actively managed with annual turnover of: 23.00 vs. VSIIX (16.00). FSCVX has a lower initial minimum investment than VSIIX: FSCVX (3000) vs VSIIX (5000000). VSIIX annual gain was more profitable for investors over the last year : -1.66 vs. FSCVX (-5.84). FSCVX (56.61) and VSIIX (56.53) have equivalent 5 years return.
FSCVXVSIIXFSCVX / VSIIX
Total Expense Ratio1.950.063,250%
Annual Report Gross Expense Ratio2.060.063,433%
Fund Existence27 years26 years-
Gain YTD2.3646.73835%
Front LoadN/AN/A-
Min. Initial Investment300050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets271M58.3B0%
Annual Yield % from dividends0.561.9828%
Returns for 1 year-5.84-1.66352%
Returns for 3 years19.5526.5174%
Returns for 5 years56.6156.53100%
Returns for 10 years55.46113.2749%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRIBX25.96N/A
N/A
MFS Research International B
AHSAX22.75N/A
N/A
Alger Health Sciences A
NBGTX33.64N/A
N/A
Neuberger Berman Large Cap Growth Tr
HADRX85.15N/A
N/A
Horizon Defined Risk Advisor
VSGEX7.51N/A
N/A
Virtus SGA International Growth C